1 / 46

Mechanism of an Aspartyl Protease

Mechanism of an Aspartyl Protease. LINK. Modeling an inhibitor after the transition state may result in a tighter-binding inhibitor. But the actual transition state (in box above) is chemically unstable, so a number of more stable “transition state isosteres” have been devised.

Download Presentation

Mechanism of an Aspartyl Protease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Mechanism of an Aspartyl Protease LINK

  2. Modeling an inhibitor after the transition state may result in a tighter-binding inhibitor But the actual transition state (in box above) is chemically unstable, so a number of more stable “transition state isosteres” have been devised.

  3. HIV Protease Inhibitors Indinavir/Crixivan

  4. HIV Protease Inhibitors Ritonavir/Norvir

  5. HIV Protease Inhibitors Nelfinavir/Viracept

  6. Amprenavir (Agenerase)

  7. The Aldol Condensation

  8. Mechanism of the Aldol Condensation

  9. Dess-Martin Periodinane

  10. Mechanism of the Dess-Martin Oxidation

  11. Reductive Amination • Note that other reducing agents can be used on the intermediate imine • The most commonly used reducing agents include NaBH3CN and NaBH(OAc)3, since these borohydrides are stable in the presence of mild acid (like AcOH), which promotes formation of the imine and also protonates the imine, thus activating it toward addition of the hydride anion.

  12. Guanidinium-derived Peptide Coupling Agents

More Related